In my last posting (Avastin/Lucentis Update 48), I wrote about the problems with Avastin injections, that appeared to be caused by non-sterile/non-aseptic techniques during re-packaging Avastin from 4 ml bottles into much smaller doses (0.05ml) in tuberculin syringes.
A colleague, who is a compounding pharmacist, pointed out to me that other things can cause contamination of the eye during intravitreal injections besides using non-aseptic techniques during dilution and packaging of Avastin into injectable syringes.
He sent me a copy of a report from Medscape Medical News that was published online following a meeting of the American Academy of (Read more...)
A colleague, who is a compounding pharmacist, pointed out to me that other things can cause contamination of the eye during intravitreal injections besides using non-aseptic techniques during dilution and packaging of Avastin into injectable syringes.
He sent me a copy of a report from Medscape Medical News that was published online following a meeting of the American Academy of (Read more...)